SCI Papers Published in 2021
Time：2022-09-22
Sun Yuanjie, Liu Zhishun*.《Annals of Internal Medicine》. (IF：25.391). Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome : A Randomized Trial.
Zhang Xing, Hua Baojin *.《Gastroenterology》. (IF：22.682). Reply to"Does Endoscopic Screening Really Not Alter the Incidence of Gastric Cancer?".
Su Xin, Xing Yanwei*.《Seminars in Cancer Biology》. (IF：15.707). Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy.
Han Man, Jiang Quan *.《Cellular & Molecular Immunology》. (IF：11.530). New insights into follicular helper T cell response and regulation in autoimmune pathogenesis.
Sun Yuanjie, Liu Zhishun*.《American Journal of Gastroenterology》. (IF：10.864). Response to Philips and Abraham.
Pang Ran，Pang Ran*.《Cochrane Database of Systematic Reviews》. (IF：9.266). Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.
Su Liang, Jiao Yongzheng*.《Advances in Nutrition》. (IF：8.701). Effect of Antioxidants on Sperm Quality Parameters in Subfertile Men: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Liu Can，Xing Yanwei*.《Pharmacological Research》. (IF：7.658). Relevance of mitochondrial oxidative stress to arrhythmias: Innovative concepts to target treatments.
Han Man，Jiang Quan*.《Frontiers in Immunology》. (IF：7.561). The Multiple Roles of B Cells in the Pathogenesis of Sjögren's Syndrome.
Lyu Wenliang, Lyu Wenliang *.《Hepatobiliary Surgery and Nutrition》. (IF：7.293). Understanding traditional Chinese medicine.
Zhang Yuqing，Lian Fengmei/Tong Xiaolin*.《Frontiers in Cell and Developmental Biology》. (IF：6.684). Signaling Pathways Involved in Diabetic Renal Fibrosis.
Li Dan，Wu Min*.《Frontiers in Cell and Developmental Biology》. (IF：6.684). Novel Insights and Current Evidence for Mechanisms of Atherosclerosis: Mitochondrial Dynamics as a Potential Therapeutic Target.
Yang Fan，Xing Yanwei*.《Frontiers in Nutrition》. (IF：6.576). Effect of Epidemic Intermittent Fasting on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Wang Xinmiao，Li Jie*.《Frontiers in Nutrition》. (IF：6.576). Efficacy and Safety of Brucea javanica Oil Emulsion Injection in the Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis.
Su Xin，Xing Yanwei*.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). The Beneficial Effects of Saffron Extract on Potential Oxidative Stress in Cardiovascular Diseases.
Xiang Mi/Lu Yingdong, Cui Xiangning*.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments.
Li xinye，Xing Yanwei*.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury.
Chang Xing， Liu Ruxiu *.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). Tongyang Huoxue Decoction (TYHX) Ameliorating Hypoxia/Reoxygenation-Induced Disequilibrium of Calcium Homeostasis and Redox Imbalance via Regulating Mitochondrial Quality Control in Sinoatrial Node Cells.
Meng Peipei，He Qingyong*.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). Molecular mechanism of astragaloside IV in improving endothelial dysfunction of cardiovascular dieseases mediated by oxidative stress.
He Qingyong.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). Shexiang Baoxin Pill for Acute Myocardial Infarction: Clinical Evidence and Molecular Mechanism of Antioxidative Stress.
An Xuedong，Lian Fengmei/Tong Xiaolin*.《Biomedicine & Pharmacotherapy》. (IF：6.529). The Direct Evidence and Mechanism of Traditional Chinese Medicine Treatment of COVID-19.
Li Yaoyuan，Hua Baojin*.《Biomedicine & Pharmacotherapy》. (IF：6.529). Can Src protein tyrosine kinase inhibitors be combined with opioid analgesics? Src and opioid-induced tolerance, hyperalgesia and addiction.
Duan Liyun， Liu Xinmin/Lian Fengmei*.《Biomedicine & Pharmacotherapy》. (IF：6.529). Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus.
Li Yaoyuan，Hua Baojin*.《Biomedicine & Pharmacotherapy》. (IF：6.529). The nonreceptor protein tyrosine kinase Src participates in every step of cancer-induced bone pain.
Chen Xin，Zheng Honggang *.《Frontiers in Oncology》. (IF：6.244). Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol.
Cheng Mengqi，Hua Baojin*.《Frontiers in Oncology》. (IF：6.244). Efficacy and Safety of Astragalus-Containing Traditional Chinese Medicine Combined With Platinum-Based Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.
Wu Min，Wu Min*.《Frontiers in Cardiovascular Medicine》. (IF：6.050). Mechanisms of Atherosclerosis Induced by Postprandial Lipemia.
Yuan Guozhen，Hu Yuanhui*.《Frontiers in Cardiovascular Medicine》. (IF：6.050). Cardiac Rehabilitation: A Bibliometric Review From 2001 to 2020.
Yang Xinyu，Xing Yanwei*.《Frontiers in Cardiovascular Medicine》. (IF：6.050). Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis.
Zhou Yan，Hu Yuanhui*.《Frontiers in Cardiovascular Medicine》. (IF：6.050). The Role of the VEGF Family in Coronary Heart Disease.
Wu Min.《Frontiers in Cardiovascular Medicine》. (IF：6.050). Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview.
Zheng Qi， Zhang Ying /Hou Wei*.《Frontiers in Cardiovascular Medicine》. (IF：6.050). Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study.
Jin De，Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF：5.810). Potential Mechanism Prediction of Herbral Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking.
Jin De，Lian Fengmei*.《Frontiers in Pharmacology》. (IF：5.810). Efficacy and Safety of TangWang Prescription for Type 2 Non-Proliferative Diabetic Retinopathy: A Study Protocol for a Randomized Controlled Trial.
Zhang Yuehong，Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF：5.810). Efficacy of Mudan Granule (Combined With Methylcobalamin) on Type 2 Diabetic Peripheral Neuropathy: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled, Parallel-Arm, Multi-Center Trial.
Zhu Guanghui，Li Jie*.《Frontiers in Pharmacology》. (IF：5.810). Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zhang Yuehong，Lian Fengmei*.《Frontiers in Pharmacology》. (IF：5.810). Lychee Seed as a Potential Hypoglycemic Agent, and Exploration of its Underlying Mechanisms.
Jin De，Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF：5.810). Panax Ginseng C.A.Mey. as Medicine: The Potential Use of Panax Ginseng C.A.Mey. as a Remedy for Kidney Protection from a Pharmacological Perspective.
Yang Shengjie，Wu Min*.《Frontiers in Pharmacology》. (IF：5.810). Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota.
Gong Xun，Jiang Quan*.《Frontiers in Pharmacology》. (IF：5.810). Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial.
Wang Heping，Li Jie*.《Frontiers in Pharmacology》. (IF：5.810). Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis.
Liu Tongtong，Zhan Yongli*.《Frontiers in Pharmacology》. (IF：5.810). Knowledge Domain and Emerging Trends in Podocyte Injury Research From 1994 to 2021: A Bibliometric and Visualized Analysis.
Zhou Rongrong，Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF：5.810). Dosage Modification of Traditional Chinese Medicine Prescriptions: An Analysis of Two Randomized Controlled Trials.
Zhao Yiqian，Wu Min*.《Frontiers in Pharmacology》. (IF：5.810). Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases.
Lian Fengmei*.《Aging (Albany NY)》. (IF：5.682). Decoding the chemical composition and pharmacological mechanisms of Jiedu Tongluo Tiaogan Formula using high-performance liquid chromatography coupled with network pharmacology-based investigation.
Dong Guangtong，Wei Junping/Hou Wei*.《Respiratory Research》. (IF：5.631). Effects of diabetes on the development of radiation pneumonitis.
Li Jun，Wei Junping*.《Frontiers in Endocrinology》. (IF：5.555). Effect of Addition of Thyroxine in the Treatment of Graves’ Disease: A Systematic Review.
Chen Yinying， Wang Jie*.《Journal of Translational Medicine》. (IF：5.531). Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks.
Chen Hairong，Tong Xiaolin*.《Journal of Oral Microbiology》. (IF：5.474). Microbial characteristics across different tongue coating types in a healthy population.
Han Lin，Zhao Linhua/Tong Xiaolin*.《Chinese Medicine》. (IF：5.455). Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking.
An Xuedong，Lian Fengmei/Tong Xiaolin*.《Chinese Medicine》. (IF：5.455). The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19.
Han Lin，Zhao Linhua/Tong Xiaolin*.《Chinese Medicine》. (IF：5.455). Mechanism exploration of Gouqi-wentang formula against type 2 diabetes mellitus by phytochemistry and network pharmacology-based analysis and biological validation.
Shang Chang, Cui Xiangning *.《Food & Function》. (IF：5.396). Beneficial effects of cinnamon and its extracts in the management of cardiovascular diseases and diabetes.
Zheng Yujiao，Li Min/Tong Xiaolin*.《Phytomedicine》. (IF：5.340). Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: a systematic review and meta-analysis.
Tian Jiaxing，Li Min/Tong Xiaolin*.《Frontiers in Cellular and Infection Microbiology》. (IF：5.293). Alleviation Effects of GQD, a Traditional Chinese Medicine Formula, on Diabetes Rats Linked to Modulation of the Gut Microbiome.
HanYi《Arthritis Research & Therapy》. (IF：5.156). Isopsoralen ameliorates rheumatoid arthritis by targeting MIF.
Zheng Yujiao，Lian Fengmei/Tong Xiaolin*.《Frontiers in Medicine》. (IF：5.091). Understanding COVID-19 in Wuhan from the perspective of cold-dampness: clinical evidences and mechanisms.
An Xuedong，Lian Fengmei/Tong Xiaolin*.《Frontiers in Medicine》. (IF：5.091). Efficacy of Jinhua Qinggan Granules Combined With Western Medicine in the Treatment of Confirmed and Suspected COVID-19: A Randomized Controlled Trial.
Zhang Xing, Hua Baojin *.《Gastroenterology》. (IF：22.682). Reply to"Does Endoscopic Screening Really Not Alter the Incidence of Gastric Cancer?".
Su Xin, Xing Yanwei*.《Seminars in Cancer Biology》. (IF：15.707). Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy.
Han Man, Jiang Quan *.《Cellular & Molecular Immunology》. (IF：11.530). New insights into follicular helper T cell response and regulation in autoimmune pathogenesis.
Sun Yuanjie, Liu Zhishun*.《American Journal of Gastroenterology》. (IF：10.864). Response to Philips and Abraham.
Pang Ran，Pang Ran*.《Cochrane Database of Systematic Reviews》. (IF：9.266). Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.
Su Liang, Jiao Yongzheng*.《Advances in Nutrition》. (IF：8.701). Effect of Antioxidants on Sperm Quality Parameters in Subfertile Men: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Liu Can，Xing Yanwei*.《Pharmacological Research》. (IF：7.658). Relevance of mitochondrial oxidative stress to arrhythmias: Innovative concepts to target treatments.
Han Man，Jiang Quan*.《Frontiers in Immunology》. (IF：7.561). The Multiple Roles of B Cells in the Pathogenesis of Sjögren's Syndrome.
Lyu Wenliang, Lyu Wenliang *.《Hepatobiliary Surgery and Nutrition》. (IF：7.293). Understanding traditional Chinese medicine.
Zhang Yuqing，Lian Fengmei/Tong Xiaolin*.《Frontiers in Cell and Developmental Biology》. (IF：6.684). Signaling Pathways Involved in Diabetic Renal Fibrosis.
Li Dan，Wu Min*.《Frontiers in Cell and Developmental Biology》. (IF：6.684). Novel Insights and Current Evidence for Mechanisms of Atherosclerosis: Mitochondrial Dynamics as a Potential Therapeutic Target.
Yang Fan，Xing Yanwei*.《Frontiers in Nutrition》. (IF：6.576). Effect of Epidemic Intermittent Fasting on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Wang Xinmiao，Li Jie*.《Frontiers in Nutrition》. (IF：6.576). Efficacy and Safety of Brucea javanica Oil Emulsion Injection in the Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis.
Su Xin，Xing Yanwei*.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). The Beneficial Effects of Saffron Extract on Potential Oxidative Stress in Cardiovascular Diseases.
Xiang Mi/Lu Yingdong, Cui Xiangning*.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments.
Li xinye，Xing Yanwei*.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury.
Chang Xing， Liu Ruxiu *.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). Tongyang Huoxue Decoction (TYHX) Ameliorating Hypoxia/Reoxygenation-Induced Disequilibrium of Calcium Homeostasis and Redox Imbalance via Regulating Mitochondrial Quality Control in Sinoatrial Node Cells.
Meng Peipei，He Qingyong*.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). Molecular mechanism of astragaloside IV in improving endothelial dysfunction of cardiovascular dieseases mediated by oxidative stress.
He Qingyong.《Oxidative Medicine and Cellular Longevity》. (IF：6.543). Shexiang Baoxin Pill for Acute Myocardial Infarction: Clinical Evidence and Molecular Mechanism of Antioxidative Stress.
An Xuedong，Lian Fengmei/Tong Xiaolin*.《Biomedicine & Pharmacotherapy》. (IF：6.529). The Direct Evidence and Mechanism of Traditional Chinese Medicine Treatment of COVID-19.
Li Yaoyuan，Hua Baojin*.《Biomedicine & Pharmacotherapy》. (IF：6.529). Can Src protein tyrosine kinase inhibitors be combined with opioid analgesics? Src and opioid-induced tolerance, hyperalgesia and addiction.
Duan Liyun， Liu Xinmin/Lian Fengmei*.《Biomedicine & Pharmacotherapy》. (IF：6.529). Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus.
Li Yaoyuan，Hua Baojin*.《Biomedicine & Pharmacotherapy》. (IF：6.529). The nonreceptor protein tyrosine kinase Src participates in every step of cancer-induced bone pain.
Chen Xin，Zheng Honggang *.《Frontiers in Oncology》. (IF：6.244). Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol.
Cheng Mengqi，Hua Baojin*.《Frontiers in Oncology》. (IF：6.244). Efficacy and Safety of Astragalus-Containing Traditional Chinese Medicine Combined With Platinum-Based Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.
Wu Min，Wu Min*.《Frontiers in Cardiovascular Medicine》. (IF：6.050). Mechanisms of Atherosclerosis Induced by Postprandial Lipemia.
Yuan Guozhen，Hu Yuanhui*.《Frontiers in Cardiovascular Medicine》. (IF：6.050). Cardiac Rehabilitation: A Bibliometric Review From 2001 to 2020.
Yang Xinyu，Xing Yanwei*.《Frontiers in Cardiovascular Medicine》. (IF：6.050). Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis.
Zhou Yan，Hu Yuanhui*.《Frontiers in Cardiovascular Medicine》. (IF：6.050). The Role of the VEGF Family in Coronary Heart Disease.
Wu Min.《Frontiers in Cardiovascular Medicine》. (IF：6.050). Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview.
Zheng Qi， Zhang Ying /Hou Wei*.《Frontiers in Cardiovascular Medicine》. (IF：6.050). Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study.
Jin De，Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF：5.810). Potential Mechanism Prediction of Herbral Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking.
Jin De，Lian Fengmei*.《Frontiers in Pharmacology》. (IF：5.810). Efficacy and Safety of TangWang Prescription for Type 2 Non-Proliferative Diabetic Retinopathy: A Study Protocol for a Randomized Controlled Trial.
Zhang Yuehong，Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF：5.810). Efficacy of Mudan Granule (Combined With Methylcobalamin) on Type 2 Diabetic Peripheral Neuropathy: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled, Parallel-Arm, Multi-Center Trial.
Zhu Guanghui，Li Jie*.《Frontiers in Pharmacology》. (IF：5.810). Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zhang Yuehong，Lian Fengmei*.《Frontiers in Pharmacology》. (IF：5.810). Lychee Seed as a Potential Hypoglycemic Agent, and Exploration of its Underlying Mechanisms.
Jin De，Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF：5.810). Panax Ginseng C.A.Mey. as Medicine: The Potential Use of Panax Ginseng C.A.Mey. as a Remedy for Kidney Protection from a Pharmacological Perspective.
Yang Shengjie，Wu Min*.《Frontiers in Pharmacology》. (IF：5.810). Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota.
Gong Xun，Jiang Quan*.《Frontiers in Pharmacology》. (IF：5.810). Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial.
Wang Heping，Li Jie*.《Frontiers in Pharmacology》. (IF：5.810). Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis.
Liu Tongtong，Zhan Yongli*.《Frontiers in Pharmacology》. (IF：5.810). Knowledge Domain and Emerging Trends in Podocyte Injury Research From 1994 to 2021: A Bibliometric and Visualized Analysis.
Zhou Rongrong，Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF：5.810). Dosage Modification of Traditional Chinese Medicine Prescriptions: An Analysis of Two Randomized Controlled Trials.
Zhao Yiqian，Wu Min*.《Frontiers in Pharmacology》. (IF：5.810). Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases.
Lian Fengmei*.《Aging (Albany NY)》. (IF：5.682). Decoding the chemical composition and pharmacological mechanisms of Jiedu Tongluo Tiaogan Formula using high-performance liquid chromatography coupled with network pharmacology-based investigation.
Dong Guangtong，Wei Junping/Hou Wei*.《Respiratory Research》. (IF：5.631). Effects of diabetes on the development of radiation pneumonitis.
Li Jun，Wei Junping*.《Frontiers in Endocrinology》. (IF：5.555). Effect of Addition of Thyroxine in the Treatment of Graves’ Disease: A Systematic Review.
Chen Yinying， Wang Jie*.《Journal of Translational Medicine》. (IF：5.531). Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks.
Chen Hairong，Tong Xiaolin*.《Journal of Oral Microbiology》. (IF：5.474). Microbial characteristics across different tongue coating types in a healthy population.
Han Lin，Zhao Linhua/Tong Xiaolin*.《Chinese Medicine》. (IF：5.455). Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking.
An Xuedong，Lian Fengmei/Tong Xiaolin*.《Chinese Medicine》. (IF：5.455). The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19.
Han Lin，Zhao Linhua/Tong Xiaolin*.《Chinese Medicine》. (IF：5.455). Mechanism exploration of Gouqi-wentang formula against type 2 diabetes mellitus by phytochemistry and network pharmacology-based analysis and biological validation.
Shang Chang, Cui Xiangning *.《Food & Function》. (IF：5.396). Beneficial effects of cinnamon and its extracts in the management of cardiovascular diseases and diabetes.
Zheng Yujiao，Li Min/Tong Xiaolin*.《Phytomedicine》. (IF：5.340). Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: a systematic review and meta-analysis.
Tian Jiaxing，Li Min/Tong Xiaolin*.《Frontiers in Cellular and Infection Microbiology》. (IF：5.293). Alleviation Effects of GQD, a Traditional Chinese Medicine Formula, on Diabetes Rats Linked to Modulation of the Gut Microbiome.
HanYi《Arthritis Research & Therapy》. (IF：5.156). Isopsoralen ameliorates rheumatoid arthritis by targeting MIF.
Zheng Yujiao，Lian Fengmei/Tong Xiaolin*.《Frontiers in Medicine》. (IF：5.091). Understanding COVID-19 in Wuhan from the perspective of cold-dampness: clinical evidences and mechanisms.
An Xuedong，Lian Fengmei/Tong Xiaolin*.《Frontiers in Medicine》. (IF：5.091). Efficacy of Jinhua Qinggan Granules Combined With Western Medicine in the Treatment of Confirmed and Suspected COVID-19: A Randomized Controlled Trial.